Cargando…

Neoadjuvant Chemotherapy for Advanced Gallbladder Cancer: Do We have Enough Evidence? A Systematic Review

BACKGROUND: Recently for advanced gallbladder carcinoma, neoadjuvant chemotherapy has emerged as an important strategy in place of adjuvant chemotherapy with the hope that it will help to improve the resectability and survival. AIM AND OBJECTIVE: The goal was to conduct a systematic review of publis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naveed, Shah, Qari, Hasina, Thau, Cao M, Burasakarn, Pipit, Mir, Abdul W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566156/ https://www.ncbi.nlm.nih.gov/pubmed/34786362 http://dx.doi.org/10.5005/jp-journals-10018-1348

Ejemplares similares

Lymph Node Ratio is an Important Prognostic Factor in Curatively Resected Gallbladder Carcinoma, Especially in Node-positive Patients: An Experience from Endemic Region in a Developing Country
por: Naveed, Shah, et al.
Publicado: (2021)

Impact of the Interval between Neoadjuvant Chemotherapy and Gastrectomy on Pathological Response and Survival Outcomes for Patients with Locally Advanced Gastric Cancer: A Meta-analysis
por: Naveed, Shah, et al.
Publicado: (2022)

Cap-assisted endoscopy: Do we have enough evidence?
por: Frieling, Thomas
Publicado: (2018)

Handgrip strength evaluation in CKD: do we have enough evidence?
por: Leal, Viviane O., et al.
Publicado: (2020)

Use of Corticosteroids in the management of Idiopathic Pulmonary Haemosiderosis: Do we have enough evidence
por: Mushtaq, Ammara, et al.
Publicado: (2015)

Dual Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Do We Have Enough Evidence?
por: Gupta, Praveen K.
Publicado: (2022)

Reply: Dual Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Do We Have Enough Evidence?
por: Singal, Aayush Kumar, et al.
Publicado: (2022)

Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?
por: Wezel, Felix, et al.
Publicado: (2017)

Analysis of preoperative risk factors for early recurrence after curative pancreatoduodenectomy for resectable pancreatic adenocarcinoma
por: Burasakarn, Pipit, et al.
Publicado: (2022)

Regulation of nanotechnology: Are we doing enough?
por: Webster, Thomas J
Publicado: (2007)

Informed consent: Are we doing enough?
por: Pranati,
Publicado: (2010)

Less is more, but are we doing enough?
por: Ñamendys-Silva, Silvio A.
Publicado: (2019)

Testosterone Replacement Therapy in Men with Untreated or Treated Prostate Cancer: Do We Have Enough Evidences?
por: Kim, Myong, et al.
Publicado: (2021)

Video laryngoscopy-guided double-lumen tube insertion: Do we have enough evidence yet?
por: Gupta, Anju, et al.
Publicado: (2022)

Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?
por: Dubský, Michal, et al.
Publicado: (2023)

Reactive lymphoid hyperplasia of the liver mimicking hepatocellular carcinoma: a case report
por: Thienhiran, Anuparp, et al.
Publicado: (2022)

Acute cholangitis caused by a huge hepatic simple cyst: a case report
por: Phancharoenkit, Nichaphat, et al.
Publicado: (2023)

Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
por: Palmeira, Vitória Andrade, et al.
Publicado: (2020)

Osteoporosis in Saudi Arabia: Are we doing enough?
por: Alwahhabi, Basmah K.
Publicado: (2015)

Bracing in clubfoot: do we know enough?
por: Alves, C.
Publicado: (2019)

Oral submucous fibrosis: Are we doing enough?
por: Chugh, Ankita, et al.
Publicado: (2019)

Vitamin D and Lupus: Are we doing enough?
por: Chiruvolu, Neha V., et al.
Publicado: (2021)

Delirium – are we doing enough prevention and basic management in acute settings?
por: Watkins, Anna, et al.
Publicado: (2021)

Vitamin C for COVID-19 Treatment: Have We Got Enough Evidence?
por: Ahmad, Siti Rohaiza
Publicado: (2022)

Hand injury prevention in India: Are we doing enough?
por: Panse, Nikhil, et al.
Publicado: (2011)

Lycopene and male infertility: do we know enough?
por: Pakrashi, Tarita, et al.
Publicado: (2014)

Diabetes Prevention and Treatment Strategies: Are we doing enough?
por: Backholer, Kathryn, et al.
Publicado: (2013)

Do We Tell Our Coronary Patients Enough?
por: Trelawny-Ross, Carol P., et al.
Publicado: (1986)

Persistence in Phytopathogenic Bacteria: Do We Know Enough?
por: Martins, Paula M. M., et al.
Publicado: (2018)

The burden of type 2 diabetes: are we doing enough?
por: Zimmet, P.
Publicado: (2003)

Cancer prevention programmes in Mexico: are we doing enough?
por: Padilla-Raygoza, Nicolás, et al.
Publicado: (2020)

Stress and depression among students: Are we doing enough?
por: Tariq, Sundus, et al.
Publicado: (2022)

Choledochal cysts type VI: biliary cyst of the cystic duct with connecting to right anterior sectoral bile duct: a case report
por: Maneepairoj, Nattaporn, et al.
Publicado: (2022)

Recent progress in sepsis epidemiology – have we learned enough?
por: Gerlach, Herwig, et al.
Publicado: (2003)

Pseudopolyps in inflammatory bowel diseases: Have we learned enough?
por: Politis, Dimitrios S, et al.
Publicado: (2017)

Do we have enough evidence how seasonal influenza is transmitted and can be prevented in hospitals to implement a comprehensive policy?
por: Thomas, Roger E.
Publicado: (2016)

Gallbladder Cancer: We Need to Do Better!
por: Shukla, Parul J., et al.
Publicado: (2009)

Mothers’ knowledge of child health matters: Are we doing enough?
por: Al-Ayed, Ibrahim H.
Publicado: (2010)

Environmental enteropathy and malnutrition: do we know enough to intervene?
por: Petri, William A, et al.
Publicado: (2014)

Hypopituitarism after subarachnoid haemorrhage, do we know enough?
por: Khajeh, Ladbon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_on1u8uo0euec97b8raaj22556q